Jim McCamant
Jim McCamant
ahead larger love
They would love to have the colorectal go ahead because that's a larger market,
clinical favor finally gene later point products stage therapy
Gene therapy has been out of favor but we're finally getting to the point where the products are in later stage clinical trials.
clinical risks seen
There's always risks when you haven't seen the clinical data.
competition market products time
There will be a lot of competition out there by the time these products get to market -- if they do.